▶ 調査レポート

下気道感染症治療の世界市場(~2026年)

• 英文タイトル:Global Lower Respiratory Tract Infection Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。下気道感染症治療の世界市場(~2026年) / Global Lower Respiratory Tract Infection Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY12541資料のイメージです。• レポートコード:MRC2-11QY12541
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は下気道感染症治療のグローバル市場について調査・分析したレポートです。種類別(サポーティブケア、ホスピタルケア、ドラッグ、ワクチン)市場規模、用途別(病院、クリニック、外来手術センター)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別下気道感染症治療の競争状況、市場シェア
・世界の下気道感染症治療市場:種類別市場規模 2015年-2020年(サポーティブケア、ホスピタルケア、ドラッグ、ワクチン)
・世界の下気道感染症治療市場:種類別市場規模予測 2021年-2026年(サポーティブケア、ホスピタルケア、ドラッグ、ワクチン)
・世界の下気道感染症治療市場:用途別市場規模 2015年-2020年(病院、クリニック、外来手術センター)
・世界の下気道感染症治療市場:用途別市場規模予測 2021年-2026年(病院、クリニック、外来手術センター)
・北米の下気道感染症治療市場分析:米国、カナダ
・ヨーロッパの下気道感染症治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの下気道感染症治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の下気道感染症治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの下気道感染症治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Sanofi Pasteur、Merck、GlaxoSmithKline、Pfizer、AstraZeneca
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia.
The global lower respiratory tract infection market is anticipated to witness lucrative growth due to increasing prevalence of lung diseases, surge in geriatric population, rise in risk of pneumonia in children, etc. According to World Health Organization (WHO), Respiratory syncytial virus (RSV) is responsible for 30 million lower respiratory tract infection cases in children worldwide, the prevalence of such viral diseases will drive the growth of the global market through 2025.

Market Analysis and Insights: Global Lower Respiratory Tract Infection Treatment Market
The global Lower Respiratory Tract Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Lower Respiratory Tract Infection Treatment Scope and Market Size
Lower Respiratory Tract Infection Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lower Respiratory Tract Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sanofi Pasteur
Merck
GlaxoSmithKline
Pfizer
AstraZeneca

Market segment by Type, the product can be split into
Supportive Care
Hospital Care
Drugs
Vaccines
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lower Respiratory Tract Infection Treatment Revenue
1.4 Market by Type
1.4.1 Global Lower Respiratory Tract Infection Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Supportive Care
1.4.3 Hospital Care
1.4.4 Drugs
1.4.5 Vaccines
1.5 Market by Application
1.5.1 Global Lower Respiratory Tract Infection Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Lower Respiratory Tract Infection Treatment Market Perspective (2015-2026)
2.2 Global Lower Respiratory Tract Infection Treatment Growth Trends by Regions
2.2.1 Lower Respiratory Tract Infection Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lower Respiratory Tract Infection Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Lower Respiratory Tract Infection Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lower Respiratory Tract Infection Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Lower Respiratory Tract Infection Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Lower Respiratory Tract Infection Treatment Players by Market Size
3.1.1 Global Top Lower Respiratory Tract Infection Treatment Players by Revenue (2015-2020)
3.1.2 Global Lower Respiratory Tract Infection Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Lower Respiratory Tract Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lower Respiratory Tract Infection Treatment Market Concentration Ratio
3.2.1 Global Lower Respiratory Tract Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lower Respiratory Tract Infection Treatment Revenue in 2019
3.3 Lower Respiratory Tract Infection Treatment Key Players Head office and Area Served
3.4 Key Players Lower Respiratory Tract Infection Treatment Product Solution and Service
3.5 Date of Enter into Lower Respiratory Tract Infection Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Lower Respiratory Tract Infection Treatment Historic Market Size by Type (2015-2020)
4.2 Global Lower Respiratory Tract Infection Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020)
5.2 Global Lower Respiratory Tract Infection Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Lower Respiratory Tract Infection Treatment Market Size (2015-2020)
6.2 Lower Respiratory Tract Infection Treatment Key Players in North America (2019-2020)
6.3 North America Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
6.4 North America Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Lower Respiratory Tract Infection Treatment Market Size (2015-2020)
7.2 Lower Respiratory Tract Infection Treatment Key Players in Europe (2019-2020)
7.3 Europe Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
7.4 Europe Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

8 China
8.1 China Lower Respiratory Tract Infection Treatment Market Size (2015-2020)
8.2 Lower Respiratory Tract Infection Treatment Key Players in China (2019-2020)
8.3 China Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
8.4 China Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Lower Respiratory Tract Infection Treatment Market Size (2015-2020)
9.2 Lower Respiratory Tract Infection Treatment Key Players in Japan (2019-2020)
9.3 Japan Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
9.4 Japan Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Lower Respiratory Tract Infection Treatment Market Size (2015-2020)
10.2 Lower Respiratory Tract Infection Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

11 India
11.1 India Lower Respiratory Tract Infection Treatment Market Size (2015-2020)
11.2 Lower Respiratory Tract Infection Treatment Key Players in India (2019-2020)
11.3 India Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
11.4 India Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Lower Respiratory Tract Infection Treatment Market Size (2015-2020)
12.2 Lower Respiratory Tract Infection Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020)
12.4 Central & South America Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Details
13.1.2 Sanofi Pasteur Business Overview
13.1.3 Sanofi Pasteur Lower Respiratory Tract Infection Treatment Introduction
13.1.4 Sanofi Pasteur Revenue in Lower Respiratory Tract Infection Treatment Business (2015-2020))
13.1.5 Sanofi Pasteur Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Lower Respiratory Tract Infection Treatment Introduction
13.2.4 Merck Revenue in Lower Respiratory Tract Infection Treatment Business (2015-2020)
13.2.5 Merck Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline Lower Respiratory Tract Infection Treatment Introduction
13.3.4 GlaxoSmithKline Revenue in Lower Respiratory Tract Infection Treatment Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Lower Respiratory Tract Infection Treatment Introduction
13.4.4 Pfizer Revenue in Lower Respiratory Tract Infection Treatment Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview
13.5.3 AstraZeneca Lower Respiratory Tract Infection Treatment Introduction
13.5.4 AstraZeneca Revenue in Lower Respiratory Tract Infection Treatment Business (2015-2020)
13.5.5 AstraZeneca Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Lower Respiratory Tract Infection Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Lower Respiratory Tract Infection Treatment Revenue
Table 3. Ranking of Global Top Lower Respiratory Tract Infection Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lower Respiratory Tract Infection Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Supportive Care
Table 6. Key Players of Hospital Care
Table 7. Key Players of Drugs
Table 8. Key Players of Vaccines
Table 9. Global Lower Respiratory Tract Infection Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Lower Respiratory Tract Infection Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Lower Respiratory Tract Infection Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Lower Respiratory Tract Infection Treatment Market Share by Regions (2015-2020)
Table 13. Global Lower Respiratory Tract Infection Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Lower Respiratory Tract Infection Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Lower Respiratory Tract Infection Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Lower Respiratory Tract Infection Treatment Players
Table 20. Global Lower Respiratory Tract Infection Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Lower Respiratory Tract Infection Treatment Market Share by Players (2015-2020)
Table 22. Global Top Lower Respiratory Tract Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lower Respiratory Tract Infection Treatment as of 2019)
Table 23. Global Lower Respiratory Tract Infection Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Lower Respiratory Tract Infection Treatment Product Solution and Service
Table 26. Date of Enter into Lower Respiratory Tract Infection Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Lower Respiratory Tract Infection Treatment Market Size Share by Type (2015-2020)
Table 30. Global Lower Respiratory Tract Infection Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Lower Respiratory Tract Infection Treatment Market Size Share by Application (2015-2020)
Table 32. Global Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Lower Respiratory Tract Infection Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Lower Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Lower Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 36. North America Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Lower Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 38. North America Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Lower Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Lower Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Lower Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 42. Europe Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Lower Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 44. Europe Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Lower Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Lower Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Lower Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 48. China Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Lower Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 50. China Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Lower Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Lower Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Lower Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 54. Japan Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Lower Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 56. Japan Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Lower Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Lower Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Lower Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 60. Southeast Asia Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Lower Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Lower Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Lower Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Lower Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 66. India Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Lower Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 68. India Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Lower Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Lower Respiratory Tract Infection Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Lower Respiratory Tract Infection Treatment Market Share (2019-2020)
Table 72. Central & South America Lower Respiratory Tract Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Lower Respiratory Tract Infection Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Lower Respiratory Tract Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Lower Respiratory Tract Infection Treatment Market Share by Application (2015-2020)
Table 76. Sanofi Pasteur Company Details
Table 77. Sanofi Pasteur Business Overview
Table 78. Sanofi Pasteur Product
Table 79. Sanofi Pasteur Revenue in Lower Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 80. Sanofi Pasteur Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Product
Table 84. Merck Revenue in Lower Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 85. Merck Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Product
Table 89. GlaxoSmithKline Revenue in Lower Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 90. GlaxoSmithKline Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Lower Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Product
Table 99. AstraZeneca Revenue in Lower Respiratory Tract Infection Treatment Business (2015-2020) (Million US$)
Table 100. AstraZeneca Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lower Respiratory Tract Infection Treatment Market Share by Type: 2020 VS 2026
Figure 2. Supportive Care Features
Figure 3. Hospital Care Features
Figure 4. Drugs Features
Figure 5. Vaccines Features
Figure 6. Global Lower Respiratory Tract Infection Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Lower Respiratory Tract Infection Treatment Report Years Considered
Figure 11. Global Lower Respiratory Tract Infection Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Lower Respiratory Tract Infection Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Lower Respiratory Tract Infection Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Lower Respiratory Tract Infection Treatment Market Share by Players in 2019
Figure 16. Global Top Lower Respiratory Tract Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lower Respiratory Tract Infection Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Lower Respiratory Tract Infection Treatment Revenue in 2019
Figure 18. North America Lower Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Lower Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Lower Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Lower Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Lower Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Lower Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Lower Respiratory Tract Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed